Press Release

Mark Farrah Associates Presents Medicare Plan Benefits in Medicare Benefits Analyzer™

Issued by Mark Farrah Associates [MFA]

Apr. 10, 2025

MCMURRAY, Penn. -- Mark Farrah Associates (MFA), www.markfarrah.com simplifies analysis of Medicare benefits and Star Quality Ratings information in Medicare Benefits Analyzer™ (MBA). This powerful web-based application presents the latest plan premiums, PCP and specialist co-pays, prescription drug tier pricing, co-pays for inpatient and outpatient procedures, specialty benefits and many additional data elements in a comparative database format. In addition, MBA includes monthly enrollment updates as well as Medicare Star Quality Ratings.

The Centers for Medicare and Medicaid Services (CMS) posted 2025 plan information on Medicare.gov on October 1^st, 2024, in preparation for the Medicare Open Enrollment period between October 15^th and December 7^th. As of early October 2024, customers have had access to this important information to analyze their positions and target opportunities in the highly competitive Medicare marketplace.

Subscribers to Medicare Benefits Analyzer™ use interactive tables and the File Export Library to download MA and PDP benefits data to assess which plans have competitive selling advantages, county by county. MBA subscriptions include Medicare Business Online™ for access to monthly enrollment data. For more information about Medicare Benefits Analyzer™, visit the product page on the Mark Farrah Associates website.

About Mark Farrah Associates (MFA)

MFA is a leading data aggregator and publisher providing health plan market data and analysis tools for the healthcare industry. Committed to simplifying analysis of health insurance business, our products include: Health Coverage Portal™, Medicare Business Online™, Medicare Benefits Analyzer™, County Health Coverage™, Health Plans USA™ and 5500 Employer Health Plus. Follow us on LinkedIn!

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.